Item 2.02 Results of Operations and Financial Condition.

On January 7, 2020, during the conference call and live webcast with the investment community announced in our January 6, 2020, press release, we disclosed that as of December 31, 2019, Arena's cash, cash equivalents and investments balance was approximately $1.1 billion. Included as Exhibit 99.1 to this Current Report on Form 8-K is an excerpt of the conference call transcript relating to the foregoing financial disclosure.

Item 7.01 Regulation FD Disclosure.

Included as Exhibit 99.2 to this Current Report on Form 8-K is a presentation titled "Building a vibrant enterprise to deliver transformational medicines," dated January 2020, which is incorporated herein by reference. We intend to utilize this presentation and its contents in various meetings with securities analysts, investors and others in connection with the Annual J.P. Morgan Healthcare Conference, commencing on January 12, 2020.

The information in this Current Report on Form 8-K, including Exhibit 99.1 and Exhibit 99.2, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits. (d) Exhibits.

99.1 Excerpt of Conference Call Transcript

99.2 Presentation titled "Building a vibrant enterprise to deliver

transformational medicines," dated January 2020

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses